Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Artesia, California


Purpose:

A multicenter, randomized, patient-masked, sham-controlled evaluation of the safety and effects on visual function of brimonidine intravitreal implant in patients with glaucomatous optic neuropathy. Patients will be followed for up to 1 year.


Criteria:

Inclusion Criteria: - Primary open-angle glaucoma in one eye - Visual acuity 20/80 or better - Intraocular pressure in the study eye ≤ 24 mm Hg - Glaucomatous visual field loss - 7 dB to - 25 dB Exclusion Criteria: - Known allergy to brimonidine tartrate - Uncontrolled systemic disease or infection of the eye - Recent eye surgery or injections in the eye - Female patients who are pregnant, nursing or planning a pregnancy


NCT ID:

NCT00693485


Primary Contact:

Study Director
Medical Director
Allergan


Backup Contact:

N/A


Location Contact:

Artesia, California
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.